勝利股份(000407.SZ):山東海洋集團受讓公司股份事項擱淺
格隆匯7月2日丨勝利股份(000407.SZ)公佈,2021年1月8日、2月7日,公司股東勝利投資、陽光人壽、齊魯檢測及諾華生物分別與山東海洋集團有限公司(簡稱“海洋集團”)簽署了《股份轉讓框架協議》,勝利投資、陽光人壽、齊魯檢測及諾華生物擬向海洋集團轉讓其所持公司合計約1.52億股股份以及由此所衍生的所有股東權益,佔公司總股本的17.22%,此外,勝利投資擬將其在股份轉讓完成後所持公司3.00%股份的表決權委託海洋集團行使。
根據《股份轉讓框架協議》相關條款約定,若各方未於2021年6月30日前簽署《股份轉讓協議》,則該《股份轉讓框架協議》自動終止。經公司與相關方瞭解,目前各方未能就《股份轉讓協議》相關內容達成最終一致並簽署。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.